Early T-cell precursor acute lymphoblastic leukaemia.

@article{Taub2009EarlyTP,
  title={Early T-cell precursor acute lymphoblastic leukaemia.},
  author={Jeffrey W. Taub},
  journal={The Lancet. Oncology},
  year={2009},
  volume={10 2},
  pages={105-6}
}
www.thelancet.com/oncology Vol 10 February 2009 105 Treatment of childhood acute lymphoblastic leukaemia (ALL) is one of the great successes in cancer therapeutics. The use of therapy based on known risk factors—eg, age at diagnosis, presenting white-blood-cell (WBC) count, leukaemia cytogenetics, and early response to therapy measured by minimal residual disease (MRD) detection—is responsible for cure being achieved in more than 80% of patients with B-precursor ALL (B-ALL), which accounts for… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 28 extracted citations

Biomarker of sensitivity to PR-104 in leukemia.

Blood • 2015
View 4 Excerpts
Highly Influenced

Computational Systems Biology

Methods in Molecular Biology • 2018

Identification of fusion genes and characterization of transcriptome features in T-cell acute lymphoblastic leukemia.

Proceedings of the National Academy of Sciences of the United States of America • 2018

Similar Papers

Loading similar papers…